In 2011 was created BDC Healthcare Venture, which is appeared as Corporate Investor. The leading representative office of defined Corporate Investor is situated in the Montru00e9al. The venture was found in North America in Canada.
We also calculated 2 valuable employees in our database.
Among the various public portfolio startups of the fund, we may underline Clementia Pharmaceuticals, Repare Therapeutics, Thrasos We can highlight the next thriving fund investment areas, such as Medical, Therapeutics. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. The fund has specific favorite in a number of founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Canada.
The standard case for the fund is to invest in rounds with 5 partakers. Despite the BDC Healthcare Venture, startups are often financed by Yaletown Partners, CTI Life Sciences Fund, BDC Venture Capital. The meaningful sponsors for the fund in investment in the same round are CTI Life Sciences Fund, Yaletown Partners, Fonds de solidaritu00e9 FTQ. In the next rounds fund is usually obtained by Yaletown Partners, Fonds de solidaritu00e9 FTQ, CTI Life Sciences Fund.
The fund is constantly included in 2-6 investment rounds annually. Considering the real fund results, this Corporate Investor is 3 percentage points more often commits exit comparing to other organizations. The important activity for fund was in 2015. Opposing the other organizations, this BDC Healthcare Venture works on 2 percentage points more the average amount of lead investments. Deals in the range of 10 - 50 millions dollars are the general things for fund. The top amount of exits for fund were in 2017.
Related Funds
Funds with similar focus
Fund Name | Location |
China Life Reinsurance | - |
Condor | Buenaventura, Colombia, Valle del Cauca |
Crane Venture Partners | England, London, United Kingdom |
Dongqi Qiye | - |
Hyperwise Ventures | Israel, Tel Aviv, Tel Aviv |
i360accelerator | Dubai, United Arab Emirates |
Junyuan Ventures | Beijing, Beijing, China |
Neostella capital | Chiyoda, Japan |
One Planet | California, United States, Walnut Creek |
Partam Hightech | Israel, Tel Aviv, Tel Aviv District |
Primwest | Geneva, Geneve, Switzerland |
PSA Group | France, Ile-de-France, Paris |
Qu Ventures | - |
Quotas Beteiligungs | Germany, Hoisdorf, Schleswig-Holstein |
Radical Investments LP | Dallas, Texas, United States |
RSK Ecosystem Fund | - |
Sante Ventures | Austin, Texas, United States |
Scaleworks | San Antonio, Texas, United States |
Xseed Partners | Andhra Pradesh, Hyderabad, India |
Zhidao Capital | China, Jiangsu, Suzhou |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
PHEMI Systems Corp. | $10M | 27 Jun 2017 | Vancouver, British Columbia, Canada | ||
Repare Therapeutics | $68M | 22 Jun 2017 | Montreal, Quebec, Canada | ||
Clearwater Clinical Limited | $6M | 12 Jan 2017 | (Old) Ottawa, Ontario, Canada | ||
Imagia | $4M | 13 Dec 2016 | Montreal, Quebec | ||
Zymeworks | $61M | 08 Jan 2016 | Vancouver, British Columbia, Canada | ||
PHEMI Systems Corp. | $9M | 11 Aug 2015 | Vancouver, British Columbia, Canada | ||
Xagenic | $11M | 09 Jul 2015 | Canada, Ontario | ||
Milestone Pharmaceuticals | $17M | 15 Jun 2015 | Montreal, Quebec, Canada | ||
Interface Biologics, Inc. | 13 Jan 2015 | Canada, Ontario |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
PHEMI Systems Corp. | $10M | 27 Jun 2017 | Vancouver, British Columbia, Canada | ||
Repare Therapeutics | $68M | 22 Jun 2017 | Montreal, Quebec, Canada | ||
Clearwater Clinical Limited | $6M | 12 Jan 2017 | (Old) Ottawa, Ontario, Canada | ||
Imagia | $4M | 13 Dec 2016 | Montreal, Quebec | ||
Zymeworks | $61M | 08 Jan 2016 | Vancouver, British Columbia, Canada | ||
PHEMI Systems Corp. | $9M | 11 Aug 2015 | Vancouver, British Columbia, Canada | ||
Xagenic | $11M | 09 Jul 2015 | Canada, Ontario | ||
Milestone Pharmaceuticals | $17M | 15 Jun 2015 | Montreal, Quebec, Canada | ||
Interface Biologics, Inc. | 13 Jan 2015 | Canada, Ontario |